Monopar Therapeutics (MNPR): Nasdaq/NYSE listing notice — Monopar receives additional 180-day Nasdaq extension to Aug 26, 2024 to meet $1 bid price rule

Monopar Therapeutics

Nasdaq granted Monopar extension to August 26, 2024 to regain compliance with $1.00 minimum bid price requirement.
Original 180-day period ended Feb 26, 2024; company failed to meet $1.00 closing bid for 10 consecutive days.
Company may consider reverse stock split if approved by shareholders to regain compliance.
No assurance of compliance; failure could lead to delisting and potential appeal.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Monopar Therapeutics received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

February 27, 2024, the Company received a letter from Nasdaq notifying that the Company had been granted an additional 180-day extension to August 26, 2024 (“Extended Compliance Period”) to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). If at any time during the Extended Compliance Period, the closing bid price of the Company’s common stock is at least $1.00 per share for a minimum of 10 consecutive business days or up to 20 business days in certain circumstances in NASDAQ's discretion, the Staff will provide written confirmation

View on SEC.gov

Browse all listing & compliance notices →

Monopar Therapeutics filing history →

Source: SEC EDGAR

accession 0001437749-24-005871

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.